Kytopen

Kytopen is a transformative biotechnology company spun out from MIT, offering a customizable yet scalable multi-solution platform that seamlessly connects the discovery, development, and manufacturing phases of cell engineering.Flowfect® is a gentle, non-viral delivery method that minimizes disruption while preserving the functionality and vitality of human cells and enhancing their biological properties by engineering immune cells, thus unlocking new therapeutic possibilities.The Flowfect® platform accelerates therapies from bench to bedside through flexibility and scalability, driving higher cell yields, faster approvals, and better outcomes based on potentially curative cell therapies.Kytopen aims to achieve simple and efficient non-viral cell therapy manufacturing in days rather than weeks to increase access for more patients.